These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2008-000547-34||Lenalidomide for Myelodysplastic Syndromes: Efficacy, Safety, Cardiac Changes, and Quality of Life (QoL-ESC RevMDS)||bad-data|
|Ongoing||2010-019710-24||A Randomized Study to Evaluate the Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QoLESS AZA-AMLE)||not-yet-due|
|Ongoing||2010-022890-33||Eltrombopag for the treatment of thrombocytopenia due to low- and intermediate risk myelodysplastic syndromes.||not-yet-due|
|Listed as ongoing, but also has a completion date||2015-000362-53||Efficacy of eltrombopag plus lenalidomide combination therapy in patients with IPSS low and intermediate-risk myelodysplastic syndrome with isolated del5q: a multicenter, randomized, double-blind, pla...||2018-09-19||bad-data|